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TO THE EDITOR
Digital clubbing with enlargement of
the distal phalanges and overcurvature
of the nails frequently occurs as a
secondary feature of chronic hypoxia
in bronchopulmonary or cardiovascular
disease and systemic inflammatory or
neoplastic processes. Genetic causes
are much less common, but their
decipherment provides a better under-
standing of those more common dis-
eases. Mutations in the 15-hydroxy-
prostaglandin dehydrogenase (HPGD)
gene encoding the major prostaglandin
(PG) PGE2-catabolizing enzyme were
the first reported cause of primary
hypertrophic osteoarthropathy (PHO),
whose most prominent feature is digital
clubbing (Uppal et al., 2008; Tariq
et al., 2009; Diggle et al., 2010;
Bergmann et al., 2011). Very recently,
Zhang et al. (2012) identified SLCO2A1
mutations in patients with autosomal
recessive PHO. Intriguingly, individuals
with PHO share many characteristics
with patients who display HO second-
ary to systemic pathologies. In addition
to digital clubbing, these are glan-
dular hypertrophy and osteoblast proli-
feration, which cause thickening of
the skin, bothersome palmoplantar
hyperhidrosis, and joint disease (pachy-
dermoperiostosis). Excessive sebum pro-
duction (seborrhea) may lead to severe
facial acne. Acroosteolysis of the distal
phalanges of the fingers and toes due to
osteoclast stimulation is also commonly
observed (Castori et al., 2005).
Termination and clearance of PG
signaling is regulated by a two-step
process (Nomura et al., 2004). First,
extracellular PGs are taken up by a
carrier-mediated process across the
plasma membrane. For many prosta-
noids (e.g., PGE2), this transport is
mediated by the PG carrier SLCO2A1
(Kanai et al., 1995). In a second step,
oxidation of prostanoids takes place
within the cell via HPGD. In this study,
we hypothesized that PHO can also be
caused by mutations in the gene en-
coding the PG transporter SLCO2A1.
SLCO2A1 is located on 3q22, com-
prises 14 exons, and encodes a 643-
amino-acid type IV transmembrane
protein that belongs to the solute carrier
organic anion transporter family (Lu
and Schuster, 1998). SLCO2A1 is
broadly expressed in fetal and adult
tissues, and it contains 12 putative
transmembrane domains, three known
N-glycosylation sites, and one KAZAL-
like domain. We performed direct
sequencing of the coding region and
adjacent exon–intron boundaries of
SLCO2A1 on an ABI 3500xL genetic
analyzer (Applied Biosystems, Darm-
stadt, Germany) in seven PHO patients
of five unrelated pedigrees who were
previously found to be negative for
mutations in HPGD. Primer sequences
and conditions are available on request.
Blood samples were collected from all
patients and family members, and
genomic DNA was extracted using
standard procedures. Institutional ap-
proval for the experiments were ob-
tained, and written patient consent and
protocols were in accordance with the
Declaration of Helsinki Principles. All
patients were of normal intelligence
and height, and did not suffer from
pulmonary disease or any other inter-
fering disease.
The 27-year-old male index patient of
consanguineous family 1 from India
(Figure 1) carries the homozygous 1-bp
deletion c.1292delC (p.Pro431LeufsX49)
in exon 9 (Figure 2). At age 25, he
complained about swelling of fingers
and toes, thickening and furrowing of
facial skin, and increasing knee pain,
which did not significantly improve
despite administration of nonsteroidal
anti-inflammatory drugs. Seborrhea was
successfully treated with 20mg per day
isotretinoin. His renal PGE2 clearance
was considerably increased (731ng per
hour per 1.73m2, normal level 4–27),
similar to PGE-M, which showed a high
clearance of 2,960ng per hour per
1.73m2 (normal 62–482).
In another consanguineous Indian
pedigree (Figure 1), we identified in both
affected brothers (26- and 28-year-old)
the homozygous missense mutation
c.763G4A (p.Gly255Arg) in exon 6.
Digital clubbing with hyperhidrosis and
pain and swelling in ankle and knee
joints started at about age 17 years.
In a 53-year-old Japanese patient, we
identified two heterozygous mutations:
c.1668G4C (p.Gln556His) in exon 12
and c.940þ 1G4A, which affects the
canonical donor splice site of intron 7.
At the age of 20 years, he recognized
enlarged wrists and ankles, with digital
clubbing and arthralgia in both knees.
X-rays showed periostosis with cortical
thickening and ectopic ossification.
PGE2 levels were significantly elevated
(1,762pgml1 in serum, normal range
25–200; and 7,063ngmmol1 creatinine
in urine, normal level o50; Cayman,
Cayman Biochemical, Ann Arbor, MI).
In a consanguineous Japanese pedi-
gree with two affected brothers, 21 and
19 years of age, we identified the above
splicing mutation c.940þ1G4A in the
homozygous state (Figure 2). PGE2
levels measured with the same enzyme
immunoassay kit were even more in-
creased in these patients. Levels were
as follows (elder brother first): 2,375
and 17,701 pgml1 in serum, and
Abbreviations: HPGD, 15-hydroxyprostaglandin dehydrogenase; NMD, nonsense-mediated decay;
PG, prostaglandin; PHO, hypertrophic osteoarthropathy
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9,260 and 17,701 ngmmol1 creatinine
in urine, respectively. Other PG meta-
bolites were not measured.
The Japanese families, both carrying
c.940þ1G4A, are not known to be
related. Interestingly, this splicing muta-
tion was also present in the heterozy-
gous state in one of the Han Chinese
patients described recently (Zhang
et al., 2012). Although we cannot prove
this, it might be hypothesized that this
mutation represents an ancient founder
allele rather than a recurrent mutation,
as our patients harbor identical
single-nucleotide polymorphisms, most
probably in cis on the same allele
(rs10935090, rs4634113, rs6767412,
rs34550074, rs117837593, http://genome.
ucsc.edu). c.940þ1G4A destructs the
canonical donor splice site of intron 7.
If the splice resulted from exon skipping
(the most common splicing mechan-
ism), this mutation would result in an
out-of-frame transcript and probably
nonsense-mediated decay (NMD).
NMD would be identical with loss-of-
function, i.e., a ‘‘most likely devastating
chatacter’’ of this mutation. NMD can
also be postulated for c.1292delC
(p.Pro431LeufsX49), identified homo-
zygously in family 1.
Overall, it might be hypothesized that
all or most SLCO2A1 mutations represent
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Figure 1. Pedigrees and phenotypes of affected individuals with SLCO2A1 mutations. Top left: clinical features of the propositus of family 1. (a) Paw-like hands
with moderate pachydermia, digital clubbing, and overcurvature of fingernails. (b) Clubbing of toes and moderate lymphoedema of lower legs. Top right: punch
biopsy of the forehead. The epidermis shows normal differentiation, whereas the upper dermis demonstrates a dense diffuse inflammatory infiltrate composed of
lymphocytes, plasma cells, and eosinophils. Some blood vessels show fibrinoid degeneration and neutrophils perivascularly with signs of cytoclasia, and some
show extravasated erythrocytes. Lymph vessels appear dilated, and mild perifollicular fibrosis can be observed. Sebaceous glands are prominent and hair
follicles contain demodex mites. Periodic acid Schiff (PAS) staining showed no other infectious agents. Mucin deposits are absent. Bottom left: (a) X-rays of ankle
joints and hands of the elder affected brother of family 2 displaying extensive soft-tissue swelling with irregular periosteal proliferation, cortical thickening, and
acroosteolysis. (b) Digital clubbing of the two affected brothers. Bottom right: (a, b) thickening and furrowing of the facial skin and digital clubbing of the hands
of both affected brothers in pedigree 4 (a, elder brother, b, younger one). Subjects in the photographs have provided written, informed consent for the
publication of their photographs.
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Figure 2. Electropherograms and localization and effect of identified SLCO2A1 mutations in the prostaglandin transporter protein. Top: (a) scheme of the
prostaglandin transporter SLCO2A1 (not drawn to scale). The SLCO2A1 protein contains 12 transmembrane domains with intracellularly located N and C terminus,
11 connecting loops in between, 3 glycosylation sites (highlighted as small circles), and a KAZAL-like domain (highlighted in bluish). The positions of the amino acids
affected by mutations identified in this study are indicated by circles (in yellow and red for the two missense mutations G255R and Q556H), a green triangle (for the
mutation c.940þ1G4A affecting the donor splice site of intron 7), and a blue square (for the frameshift mutation p.Pro431LeufsX). Below are depicted the respective
electropherograms of all SLCO2A1mutations identified in this study. The propositus of family 3 carried two heterozygous mutations, whereas the patients of the other
families showed homozygosity for this locus in line with parental consanguinity in all three pedigrees. Middle: (b) conservation of the amino acids Gly (G) 255 and
Gln (Q) 556 in SLCO2A1. The two missense mutations p.G255R and p.Q556H affect evolutionarily highly conserved amino acids in the SLCO2A1 protein
(highlighted in yellow and red). Bottom left: (c) protein modeling of the missense mutation p.Gly255Arg in comparison with the wild-type (WT) sequence of
SLCO2A1. Illustrated is the amino-acid region comprising amino acids 35–392 (only the protein ribbon is pictured). Both sequences (WT in green, mutated sequence
in blue) put on top of each other. The corresponding position (Gly255) is marked in different colors (WT: yellow; mutated amino acid: red). The protein conformation
has changed considerably; glycine (polar, neutral) present in the WT sequence is known to be much smaller than the basic amino acid arginine present in the mutant
protein, whose side chain consists of a three-carbon aliphatic straight chain. Bottom right: (d) protein modeling of the missense mutation p.Gln556His in comparison
with the WT sequence of SLCO2A1 according to the given illustration for p.Gly255Arg. Shown is the protein region comprising amino acids 529–579. WT glutamine
is a polar and neutral amino acid that has been exchanged by the basic residue histidine with an imidazole ring, causing marked conformational changes.
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truncating alleles or affect residues that
are indispensable for PG transporter
activity, such as the missense muta-
tions c.763G4A (p.Gly255Arg) and
c.1668G4C (p.Gln556His) identified.
Both changes are nonconservative, affect
evolutionarily highly conserved amino
acids (Figure 2), and were predicted
in silico by all bioinformatic tools of
pathogenic relevance (Supplementary Ta-
ble 1 online). The pathogenic character
of c.763G4A (p.Gly255Arg) and the
impact of the glycine residue at position
255 is further strengthened by the fact
that the same codon was mutated
(c.764G4A; p.Gly255Glu) in a patient
described by Zhang et al. (2012). To
corroborate these data, we constructed
molecular models of wild-type and
mutated SLCO2A1 proteins to visualize
changes of protein folding and structure
(Meng et al., 2006; Bordoli et al., 2009;
Yang et al., 2011). Both mutations are
located in a transmembrane domain
and considerably affect the protein
structure (Figure 2), which was addi-
tionally confirmed by Ramachandran
plots (Supplementary Figure S1 online).
In this report, we show that
SLCO2A1 is a frequent cause of auto-
somal recessive PHO, confirming the
data recently published by Zhang et al.,
2012. Although most patients harbor
mutations in HPGD and SLCO2A1,
further genetic heterogeneity is likely,
and candidate approaches targeting
other PG-signaling components seem
promising.
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TO THE EDITOR
In atopic dermatitis (AD), lymphocytes
have an important role via regulation of
the immune response, production of
Igs, and sustaining cutaneous inflam-
mation.
In AD, activated T cells can be found
in blood, and most importantly in
affected skin a marked increase of
activated T cells is present (Akdis
et al., 2006). Serum levels of T-cell
chemokines CCL17 (thymus and activa-
tion regulated chemokine, TARC) and
Abbreviations: AD, atopic dermatitis; CsA, cyclosporine A; EC-MPS, enteric-coated mycophenolate
sodium; FUCT-VII, fucosyl transferase VII; MPA, mycophenolic acid; TARC, thymus and activation
regulated chemokine; TNF–AIP3, tumor necrosis factor–alpha inducible protein-3
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